PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

4m short sold, page-14

  1. 77 Posts.
    lightbulb Created with Sketch. 30
    ruff, maybe some basic analysis is needed.
    how much money do they have now (it was $72m at end of march 2023)? = $60m?
    how much is current burn rate = $10m each quarter
    is it a fair expectation to think costs double to $20m a quarter when trials actually start (from maybe October 2023)? = I think yes.
    so if you put that into the spreadsheet, with a little generosity it looks like this:
    current = $62m
    1 quarter (current quarter) costs at $10m
    fourth quarter 2023 costs go up to $20m
    they go into christmas with about $32m in the bank (ex any rebate)
    that all looks way too risky for me and absolutely is investment advice.
    what does mr mozz say, do your own research. well do a simple spreadsheet and ask yurself if you like the financial situation the company has put itself in
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.